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ABSTRACT: Bioinspired citrate−carbonate−apatite (cAp)
nanocrystals doped with divalent transition metal (M) ions,
i.e., Mn2+, Co2+, and Ni2+, were prepared by batch thermal
decomplexing of Ca2+/M/citrate/phosphate/carbonate solu-
tions at 80 and 37 °C, with initial Ca2+/M molar ratios of 9:1
and 5:5, and at different crystallization times ranging from 1 to
96 h. A thorough chemical, crystallographic, and morpho-
logical characterization was carried out on the doped
nanocrystals revealing that (i) using similar crystallization
conditions the amount of incorporated M normally followed
the order Mn2+ > Co2+ > Ni2+; (ii) the growth of nanocrystals
was clearly enhanced at 80 °C and when a lower amount of M
was incorporated in the crystal structure; (iii) the increase of
the M content increased the aspect ratio (length/width) of the M-doped cAp nanocrystals compared to undoped ones, (iv) the
incorporation of the 6.5 wt % of M is a threshold for the long-range order of the nanocrystal; in fact, with a higher M content,
amorphous materials were mainly produced. Additionally, we found that citrate controlled the activity of hydrated M ions in
solution, the extension of the doping process, and protected the M ions against oxidation in solution as well as in the outermost
layer of doped nanocrystals. Preliminary in vitro cytotoxicity studies on the murine MS1 endothelial cell line showed that the
produced Mn2+- and Co2+-doped nanocrystals were highly biocompatible at doses comparable to those of undoped ones, with
the exception of the nanocrystals substituted with the highest Co2+ content at the higher doses.
1. INTRODUCTION
Apatite (Ap) nanocrystals are widely used in orthopedics,
dentistry, and more recently also for other exciting nano-
technological applications as drug nanocarries, nanocatalysts,
and fertilizers due to their well-known properties of
biocompatibility, biodegradability, osteoinductivity, and ability
to link a wide range of molecules to a high extent.1−4 In
addition, it is well reported that Ap nanocrystals having features
very close to those present in bone in terms of size, chemical
composition, and morphology, the so-called “biomimetic” Ap,
display enhanced biological and technological performances.5−7
Therefore, many synthetic methodologies to prepare “bio-
mimetic” Ap nanocrystals have been developed in the last few
years,1,8−10 and in most of them organic templates or additives
were used to finely control nucleation and crystal growth.10−12
Recently Delgado-Loṕez et al. prepared bioinspired citrate−
carbonate−apatite (cAp) nanocrystals having mean lengths
ranging from 20 to 100 nm by batch thermal decomplexing of
calcium/citrate/phosphate/carbonate solutions.13 Citrate was
employed as an organic additive during the Ap synthesis
because it was found that it is strongly bound to bone Ap
surface, and it accounts for about 5.5 wt % of the total organic
component of bone tissue.14 The presence of citrate in the
reaction environment enables the formation of homogeneous
metastable solutions at pH > 8.3, avoiding the instantaneous
nucleation of calcium carbonate or calcium phosphate.13,15 At
the same time, the increase of the temperature produces a
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gradual and homogeneous release of Ca2+ ions leading to the
formation of amorphous calcium phosphate (ACP) that
transforms to nanocrystalline carbonate apatite platelets with
citrate adsorbed on the surface.16 Citrate plays the dual role of
driving a growth pathway via an amorphous precursor and
controlling the size of the nanocrystals by the nonclassical
oriented aggregation mechanism.17 Moreover, cAp nanocrystals
display excellent biocompatibility properties in cell biological
systems,13 and it was demonstrated that they can be used as
pH-responsive delivery system of the anticancer drug
doxorubicin inside cells.18
Ap nanocrystals doped with foreign ions have also recently
attracted remarkable attention, since the ionic substitution is a
powerful tool to improve their performances for different
applications.19 Substitution of doping ions (i.e., cations and
anions) in the Ap crystal lattice can commonly occur. Indeed,
bone Ap nanocrystals are substituted with several foreign ions
such as CO3
2−, HPO4
2−, SiO4
4−, Na+, Mg2+, Mn2+, and other
minor elements.1 Because of its high flexible structure, Ap can
host monovalent, divalent, and even trivalent cations, as well as
simple monovalent anions or oxoanions.19,20
The aim of this work is the preparation and characterization
of bioinspired cAp nanocrystals doped with different functional
metal (M) ions by the method of thermal decomplexing of
calcium/M/citrate/phosphate/carbonate metastable solu-
tions.13,15−17 Three divalent M cations, such as Mn2+, Co2+
and Ni2+, were selected as doping ions to modify the crystal
structure of the nanocrystals and to improve their features for
novel or better biological and technological applications.
Mn2+ ion plays an important role in bone metabolism since it
influences regulation of bone remodeling, and its deficit causes
reduction of organic matrix synthesis and retards endochondral
osteogenesis.21 Mn2+-doped carbonate-Ap nanocrystals pro-
mote human osteoblasts proliferation, activation of their
metabolism and thereby bone growth.22 The presence of
Mn2+ in the crystalline structure of Ap was also found to
positively influence the adhesion of bone cells to an implant
material, their spread and viability.23 In view of this, the Mn2+
ion can be considered as an optimal agent to improve the
osteoconductivity and osteointegration of cAp-based materials
for bone tissue engineering.
Co2+ ion is well reported as an antibacterial and antiviral
agent in various organic complexes.24 Nanocrystalline Ap
doped with Co2+ presents antibacterial activity against different
strains, i.e., Staphylococcus aureus, Micrococcus luteus, and
Shigella f lexneri.20 Moreover Ap enriched with a large content
of Co2+ ions was found to display a highly beneficial effect for
osteoporotic bone tissue regeneration.25 As a result, Co2+ can
be effective to provide antimicrobial and antibacterial properties
to cAp nanocrystals with the final aim to manufacture
multifunctional materials for bone and dental applications.
Furthest from the biomedical field, Ni2+ is one of the most
active M ions able to catalyze many interesting reactions,26,27
and also Ap has been reported as a recyclable low-cost material
to support catalysts for organic synthesis.28 Recently, Ni2+-
substituted Ap has revealed good catalytic activity in the
process of methane dry reforming.29 Therefore, the addition of
Ni2+ ions in the cAp structure can be useful to prepare not-
hazardous and biodegradable “green” material as a heteroge-
neous nanocatalyst.
In this work, the physical−chemical and crystallographic
properties of the prepared M-doped cAp nanocrystals have
been thoroughly characterized to assess the influence of the
selected ions on the chemical and structural properties of the
cAp. Moreover, the biocompatibility of Mn2+- and Co2+-doped
nanocrystals has been characterized in the murine MS1
endothelial cell line to evaluate their possible use for biomedical
applications.
2. MATERIALS AND METHODS
2.1. Reagents. Calcium chloride dihydrate (CaCl2·2H2O, Bioxtra,
≥ 99.0% pure), nickel chloride hexahydrate (NiCl2·6H2O, ACS
reagent, purity = 99.999%), manganese chloride tetrahydrate (MnCl2·
4H2O, ACS reagent, purity), cobalt chloride hexahydrate (reagent
grade), sodium citrate tribasic dihydrate (Na3(Cit)·2H2O where Cit =
citrate = C6H5O7, ACS reagent, ≥ 99,0% pure), sodium phosphate
dibasic (Na2HPO4, ACS reagent, ≥ 99.0% pure) and sodium
carbonate monohydrate (Na2CO3·H2O, ACS reagent, 99.5% pure),
and hydrochloric acid (HCl, ACS reagent, 37 wt % in H2O) were
provided by Sigma-Aldrich. All solutions were prepared with ultrapure
water (0.22 μS, 25 °C, Milli-Q, Millipore).
2.2. Crystallization Methods. The experiments were carried out
by thermal treatment of metastable solutions containing Ca2+/M-
citrate complexes in the presence of phosphate and carbonate ions, at
pH = 8.5 (where M is Mn2+, Co2+, or Ni2+). Materials were
synthesized on the basis of the procedure reported elsewhere.13 Briefly,
two solutions of (a) x CaCl2 + y MCl2 (x = 0.09 or 0.05 M and y =
0.01 or 0.05 M, to get 9:1 and 5:5 molar ratios, respectively) + 0.4 M
Na3(Cit) and (b) 0.12 M Na2HPO4, + 0.2 M Na2CO3 were mixed (1:1
v/v, 200 mL total) at 4 °C, and the pH was adjusted to 8.5 with
diluted HCl. The undoped sample (cAp) was obtained using a 0.10 M
CaCl2 M-free solution in the aforementioned procedure. The mixed
solution was introduced in a 250 mL round-bottom flask, sealed with a
glass stopper and, without delay, immersed in a water bath at 80 °C. A
set of experiments using an initial 9:1 Ca/M ratio was also carried out
at 37 °C to assess the influence of the temperature. The crystallization
experiments were stopped at different maturation times ranging from 1
to 96 h. Once finished, the precipitates were subjected to three
consecutive cycles of washing by centrifugation with ultrapure water.
Afterward they were freeze-dried overnight at −50 °C under a vacuum
(3 mbar).
2.3. Characterization Methods. The study of the speciation of
Ca2+-citrate and M-citrate aqueous solutions as a function of the
temperature was carried out to assess the stability of these complexes
in solution prior the crystal precipitation and to correlate their
activities with the amount of metal incorporated in the crystalline
structure of the precipitates. Calculations were performed with
Phreeqc speciation software30 with the minteq v4.dat database using
the initial Ca/M ratio 9:1 at pH 8.5. The aqueous species considered
in the calculations are shown in Supporting Information.
The M, Na, Ca, and P contents were determined by inductively
coupled plasma-optical emission spectrometry (ICP-OES) using a
PerkinElmer Optima 8300 spectrometer. Samples were dissolved in 1
wt % ultrapure nitric acid and analyzed in triplicate. The crystallo-
graphic characterization and the microstructural analysis (average
crystal size and shape) were carried out by powder X-ray diffraction
(PXRD). PXRD patterns were collected in reflection mode (on a Si
flat sample holder), using a Cu Kα radiation (Kα2/Kα1 = 0.476) on a
PANalytical X’Pert PRO MPD diffractometer equipped with a PIXcel
RTMS detector operating at 45 kV and 40 mA. For the incident beam,
fixed antiscatter and divergence slits of 1° and 0.5°, respectively, were
used. The 2θ range varied from 5° to 104° with a step size of (2θ)
0.013°. The Rietveld refinement of collected X-ray diffraction (XRD)
data was accomplished by using the Fullprof software package.31
Transmission electron microscopy (TEM) observations as well as
selected area electron diffraction (SAED) and energy-dispersive X-ray
spectroscopy (EDS) analysis were performed with a STEM Philips
CM 20 microscope operating at 80 kV. The powder samples were
ultrasonically dispersed in ethanol (absolute, ≥99.8%), and then a few
droplets of the slurry were deposited on conventional copper
microgrids prior to observation. The analysis of the electrophoretic
mobility (ζ-potential) of samples was performed in a Zetasizer Nano
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analyzer (Malvern, UK) using disposable folded capillary cells at 25
°C. Samples were prepared by suspending particles in deionized water
with pH ∼ 6.5.
2.4. Cytotoxicity Tests. The murine MS1 endothelial cell line was
maintained in Dulbecco’s modified Eagle’s medium (DMEM), 10%
fetal calf serum, 50 U/mL penicillin, and 50 μg of streptomycin
(complete medium), by transplanting them twice a week. For toxicity
tests, cells were incubated (10 × 103/0.4 cm2 microwell) for 24 h; then
different concentrations of M-doped and control undoped nano-
particles were added in 100 μL of complete medium. Soluble
doxorubicin hydrochloride (DOXO, C27H29NO11HCl, 98.0−102.0%
HPLC grade) was used as a control toxic reagent. After 2−3 days
incubation, cells viability was evaluated by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) (MTT) colorimetric assay.
Briefly, 20 μL of MTT solution (5 mg mL−1 in a PBS solution) was
added to each well. The plate was then incubated at 37 °C for 3 h, and
then the supernatants were carefully aspirated. Afterward, 125 μL of
0.2 M HCl isopropanol was added to dissolve formazan crystals. A 100
μL aliquot was then removed carefully, and the optical density was
measured in a multiwell reader (2030 Multilabel Reader Victor TM
X4, PerkinElmer) at 570 nm. Viability of parallel cultures of untreated
cells was taken as 100% viability, and values obtained from cells
undergoing the different treatments were referred to this value.
Experiments were performed four times using three replicates for each
sample.
2.5. Statistical Analysis. Experiments were carried out in
triplicate, and data are expressed as mean ± standard error. Statistical
analyses were performed using independent t tests for two groups
comparisons and a one-way analysis of variance (ANOVA), after
checking homogeneity of variance using Levene’s test, in the case of
multiple comparisons. ANOVA was followed by postdoc Scheffe’́s test.
Differences at p < 0.05 were considered to be statistically significant.
3. RESULTS
3.1. Thermal Destabilization of Metal-Citrate Com-
plexes and Metal Substitution in the cAp Nanocrystals.
Figure 1 shows the evolution of the calculated ionic activities of
M-citrate complexes and the free solvated M cations as a
function of temperature. Ca(citrate)− revealed higher activity
than Co(citrate)−, Mn(citrate)−, and Ni(citrate)2
4−, respec-
tively. Similarly, free Ca2+ displayed higher activity in
comparison to the other free solvated ions (i.e., Mn2+, Co2+,
and Ni2+). The fact that the activities of all M-citrate complexes
decrease as a function of the temperature, because of their
thermal destabilization, validates the application of the thermal
decomplexing method for precipitating M-doped apatites in the
presence of citrate.
On the basis of these data, only in the case of Ni2+, whose
activity was very low, the Ca2+ ions within the apatite structure
could be replaced with a low efficiency. The calculations also
suggest that the different stability of the M-citrate complexes
and their evolution with the temperature can be a key factor
influencing the doping of the apatitic structure.
The M content of the doped nanocrystals is shown in Figure
2, for (9:1) initial Ca/M molar ratio at 80 °C, and in Figure S1
for samples prepared in the rest of studied conditions. At 80
and 37 °C the higher M content was found in samples prepared
in the presence of Mn2+, rather than in those precipitated in the
presence of Co2+ and Ni2+, in agreement with the order in
which the activities of these ions decreased in solution. At 80
°C, the Ca/M ratio 5:5 significantly favored the incorporation
of M irrespective of its nature, and, in this regard, it is worth
noting that in some samples the Mn2+ content was almost twice
of that of Ca2+ (Table S1, Supporting Information).
In the cases of Mn2+ and Co2+ the doping process is
controlled by the thermal evolution of the ionic activities in
solution, which are temperature-dependent. In fact, Mn-doped
cAp crystals showed less Mn2+ content at 80 °C than at 37 °C
in agreement with the decrease of Mn2+ activity with
temperature. In contrast, Co-doped crystals showed a higher
Co2+ content at the highest temperature, since the activity of
free Co2+ increased with temperature. Differently, the amount
of Ni2+ inside the apatitic structure did not follow a trend as a
function of temperature because of its very low activity in
solution. The time evolution of M content shows that Mn2+
and Ni2+ are incorporated during the first 4 h of reaction, and
then the content of these elements remains almost constant
(Figure 2). Only in the case of Co2+ a linear increase in the
amount of M incorporated as a function of time has been
found.
The full elemental composition including the weight
percentage of Ca, P, and Na, and the (Ca+M)/P and Ca/M
molar ratios, is shown in Table S1 of Supporting Information.
Figure 1. Calculated ionic activities of Ca(citrate)−, M-citrate
complexes, and the free solvated cations as a function of the
temperature, for the (9:1) initial Ca/M molar ratio.
Figure 2. Transition metal content (w/w%) as a function of
maturation time in the M-doped cAp nanoparticles prepared at 80
°C with an initial Ca/M ratio of 9:1.
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The (Ca+M)/P molar ratio of all the studied samples did not
significantly vary as a function of maturation time revealing only
slight changes in the structural composition of M-doped cAp
nanocrystals. Conversely, the Ca/M molar ratio was signifi-
cantly affected by the different M content that is able to enter
and substitute for Ca2+ ions in the apatitic structure.
It was already reported that cAp nanocrystals obtained by the
thermal decomplexing technique are covered by adsorbed
citrate and counterions.14 Herein we show that this layer
(composed of citrate and Na+) can be removed by washing the
crystals in a basic solution (NaOH 0.1 M). In fact, FTIR
spectroscopy revealed that the characteristic asymmetric
stretching mode of − COO− groups of citrate ions at 1595
cm−113,15 practically disappears after this treatment (Figure S2
of Supporting Information). FTIR spectra of M-doped cAp
nanoparticles (Figure S2) also showed the main broad band at
∼1030 cm−1 with a shoulder at around 1074 cm−1
corresponding to the asymmetric stretching mode of PO4
3−
groups and the bands at ∼962 cm−1 and ∼603 cm−1 ascribed to
the symmetric stretching and bending mode of PO4 groups,
respectively. The presence of CO3
2− bands at ∼1465 cm−1 and
∼880 cm−1 (shoulder) indicated that CO32− ions replaced the
−OH groups (A-type carbonation).13 The absence of bands at
3567 and 631 cm−1 corresponding to the stretching and
librational modes of OH groups confirmed the A-type
carbonate substitutions. Additionally the presence of the
bands at 1415 and 873 cm−1 proved also the existence of B-
type carbonate substitutions (CO3
2− replacing PO4
3− groups).
The elemental analysis (Table S1, Supporting Information)
revealed that the Na+ content in the washed samples decreased
significantly with respect to the unwashed precipitates
indicating that the major part of Na+ was entrapped in the
surface layer. On the contrary, the M content remained almost
unantered when the citrate layer was removed, proving that
most of M was incorporated into the apatite structure. An
additional result found in the washed samples was that the Na+
content was similar regardless of the nature of the transition
metal (Mn or Co) and the initial Ca/M ratio (see Table S2 of
Supporting Information). The amount of Na+ and M in the
analyzed samples suggests that the metal composition for the
M-doped nanoparticles can be represented by the general
chemical formula: Ca5‑x‑yNa2xMy.
Interestingly, the formation of M-citrate complexes in
solution prevents the oxidation of Mn2+ at basic pH, and,
moreover, the citrate coating around the crystals avoids metal
oxidation of the doped nanocrystals. In fact, after removing the
citrate coating with 0.1 M NaOH a change of color from white
to brown occurred, indicating the oxidation from Mn2+ to
Mn3+/4+ (Figure 3a). The structure and sizes of the doped
apatites, however, remained unaltered after this treatment since
the XRD patterns of the as-synthesized and washed samples
were similar (Figure 3b). This fact indicates that oxidation of
manganese took place at the outermost layer of the doped
nanocrystals.
3.2. Microstructure of M-Doped cAp Nanocrystals.
The XRD diagrams of the samples prepared at the different
conditions (Figure S3, Supporting Information) showed the
diffraction peaks of hydroxyapatite single phase. Concerning
the interpretation of our experimental XRD patterns, we
adopted the hexagonal symmetry for this phase, according to
(JCPDS 9-432), for the sake of practice and simplicity. Thus,
the characteristics reflections appear at 2θ 25.87° (plane 00.2),
the broad peak due to the triplet at 31,77°, 32.19°, and 32.90°,
which correspond to planes 21.1, 11.2, and 30.0 and other main
peaks at 39.81°, 46.71°, 49.46°, and 53.14°, which correspond
to the planes 31.0, 22.2, 21.3, and 00.4 respectively.32
The Rietveld refinements were performed using the FullProf
program.31 The unit cell parameters, obtained from the most
crystalline samples by DICVOL04,33 belong to the hexagonal
system, space group P63/m, and they were the same as those
reported for hydroxyapatite. The refinements started from the
atomic positions reported by Wilson et al.34 (in which structure
the carbonate groups are included), constraining the
composition of transition M and Ca according to the M
content calculated by ICP-OES. The peak profiles were
described by a Thompson−Cox−Hastings (TCH) pseudo-
Voigt profile function, whereas a Chebychev polynomial was
used for the background description.
The parameters that were systematically refined included the
unit cell (a and c; 2), preferred orientation (1), size and shape
(anisotropic Lorentzian size broadening by spherical harmonics
in the Laue class 6/m; 3), isotropic strain (1), background (15),
and overall B-factor (1). The refinements presented great
robustness and repeatability for all samples (see Figure 4
showing the fitting for two of the samples: Mn(9:1)-Ap-2h-80
°C and Co(9:1)-Ap-48h-80 °C).
The microstructural analysis provided the average crystallite
size, i.e., the mean size of the diffractive crystal domains
Figure 3. (a) Picture showing the effect of the metal oxidation when removing the citrate coating in a Mn-doped cAp sample (Mn(9:1)-96h-80 °C):
samples before (white powder) and after washing (brown powder) with 0.1 M NaOH solution; (b) XRD diagrams of the samples before and after
washing with 0.1 M NaOH.
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(referred to the volume of these domains). The standard
deviation in those values corresponds to the anisotropy of the
crystal domains, since anisotropic size broadening corrections
were applied.
The average crystallite sizes for the different samples are
reported in Table 1. The largest crystallites were found for cAp,
and then the average sizes decreased gradually from Ni-, Co-,
and Mn-doped samples. Temperature and Ca/M ratio affected
significantly the crystallite sizes. In fact, the samples prepared at
37 °C showed lower values than those obtained at 80 °C.
Similarly, samples prepared with the Ca/M ratio of 5:5 were
smaller than those prepared with the Ca/M ratio of 9:1.
The dimensions of the crystal domains were estimated also in
the different directions of the crystals, besides the average
crystallite size. The cAp crystals, with a hexagonal unit cell
(Laue group 6/m), show two main dimensions, D00.l and Dhk.0,
that are the longest and the shortest, respectively. The average
size of crystal domains reported in Table 2 are related to the
samples prepared at 80 °C using a Ca/M initial ratio of 9:1 (see
Table S3 in Supporting Information for data relative to the
other M-doped cAp nanocrystals).
The values of D00.l are clearly higher than those of Dhk.0
indicating that the crystal domains were elongated along the c-
axis.
3.3. Crystal Growth of M-Doped cAp Nanocrystals.
The growth behavior of the nanocrystals as a function of time is
shown in Table 1 and in Figure S4 of the Supporting
Information. Crystal growth is faster during the first
crystallization stages, whereas growth cessation is observed at
the longer times of each run.
The growth of nanocrystals is clearly enhanced when
temperature increased and the M content decreased, Ni-
doped cAp nanocrystals showing the highest growth while
those doped with Co and Mn the lowest. In the absence of M,
i.e., undoped cAp, the growth is even faster. Thus, the doping
process directly affected the final size and shape of the
nanocrystals in the sense that a lower M content yielded longer
and wider crystals. The plot of the average crystallite size versus
the percentage of M content for crystallization times of 2, 4, 48,
and 96 h graphically reports this trend (Figure 5). Interestingly,
a crystal size of around 20 Å (2−3 unit cells) was found above
6.5% of M content, in all the cases. This size can be considered
the frontier between crystalline and amorphous structures.
On the other hand, we found that the higher the M content
the more difficult the growth is in the (10.0) and equivalent
planes of cAp nanocrystals. The reason is likely due to the
stronger (shorter) bond of the citrate molecules with M than
with Ca in the outermost apatite layer, i.e., d(Ca(II)−O) ≈ 2.4
Å; d(Mn(II)−O) ≈ 2.2 Å; d(Co(II)−O) ≈ 2.1 Å; d(Ni(II)−
O) ≈ 2.1 Å. In a thorough study about the Co-doped
hydroxyapatite particles produced in the absence of carboxy-
lated molecules by Veselinovic et al.,35 the authors showed that
samples with higher Co2+ content display not only smaller sizes
but also lower aspect ratio than undoped particles. In
agreement with these results, herein we prove that citrate
plays a decisive role in shaping the M-doped nanocrystals,
avoiding the growth in the (hk.0) planes and yielding
nanoparticles with greater aspect ratios.
Another interesting result of the microstructural study is that
the volume of the unit cell varies between different samples and
decreases with crystallization time (Figure 6a). This can be
explained by the crystal size, which, in fact, presents an indirect
relationship with the unit cell volume: the smaller the crystals,
the bigger the cell volume (Figure 6b). In all cases the variation
of the unit cell is more pronounced in the a than in the c
parameter (Table S4, Supporting Information). This suggests
that the citrate anions bind more strongly to the outermost
(hk.0) planes as the transition M content increases, and then,
the few unit cells in the nanocrystals are more deformed than in
the bulk of bigger crystals. In fact, the strain is bigger in smaller
crystals, and therefore, in crystals that were precipitated at
shorter reaction times (Figure S6, Supporting Information).
Figure 4. Examples of Rietveld refinements of the samples (a)
Mn(9:1)-Ap-2h-80 °C and (b) Co(9:1)-Ap-48h-80 °C, showing the
excellent agreement between the observed and calculated diffraction
patterns. The average crystallite size (isotropic), the calculated sizes
(D00.l and Dhk.0), and the shape of the crystalline domains are shown in
the inset.
Table 1. Average crystallite size (Å) and relative standard
deviation (as Anisotropy, in parentheses), of cAp and M-
doped cAp nanocrystals synthesized at 80 °C using the initial
Ca/M molar ratio of 9:1
time/h cAp Mn-cAp Co-cAp Ni-cAp
1 68.8(39.9) 35.9(22.3) 52.5(66.1) 43.6(21.3)
2 67.3(38.0) 45.6(26.8) 61.9(36.0) 64.8(30.6)
4 70.8(39.4) 47.5(25.6) 66.3(35.3) 71.6(31.9)
48 110.6(36.6) 66.2(35.1) 92.1(35.6) 106.5(40.6)
96 127.1(46.6) 77.3(41.8) 97.7(39.1) 118.7(48.0)
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3.4. Size and Shape Distribution by TEM. TEM analyses
were carried out on the samples prepared with the longest
crystallization time (96 h). The mean length (L) along the
longest axis, the mean width (W), and the mean aspect ratio (R,
ratio between L and W) were determined from TEM
micrographs of samples precipitated with Ca/M ratio 9:1
using 40−50 particles in each micrograph (Figure 7a−c).
The L and W values of the nanocrystals (which correspond
to the dimensions in the [00l] and [hk0] directions,
respectively) decreased gradually from the undoped cAp to
Ni-, Co-, and Mn- doped cAp nanoparticles (in this order),
showing a correlation with the content of transition M (Table
3). It is worth noting that W values are strongly affected by the
presence of transition M in the cAp structure. The values of the
aspect ratio R, which correspond to the anisotropy in the shape
of the crystals, increased in the opposite order, so the higher the
M content the more pronounced the anisotropy is, yielding
more elongated morphologies. This can be clearly observed, for
example, when comparing Mn- and Ni-doped nanoparticles
(Figure 7a,c).
The results for the average sizes and shapes obtained from
TEM observations were in rather good agreement with the
average crystallite sizes calculated by microstructural analysis
(Table 3), suggesting that individual particles correspond to
single crystals. On the other hand, samples with a higher M
content show much smaller sizes, and the particles appear
agglomerated, so their size could not be estimated, as is the case
of the Mn(5:5) sample (Figure S5 of Supporting Information).
3.5. ζ-Potential of M-Doped cAp Suspensions. cAp
suspensions showed the most negative ζ-potential (−51.4 mV)
followed by the suspensions of Mn- and Ni-doped cAp
nanocrystals, whose values were −21.7 and −19.9 mV
respectively. This finding indicated a decrease of the colloidal
stability when cAp was doped with transition metals. A higher
ζ-potential of −6.9 mV was measured in Co-doped cAp,
indicating that this was the less stable suspension.
Table 2. Average size (D) of crystal domains along the [00.l] and [hk.0] directions of cAp and M-doped cAp nanocrystals
synthesized at 80 °C using the initial Ca/M molar ratio of 9:1
cAp Mn-Ap Co-Ap Ni-Ap
time/h D00.l/Å Dhk.0/Å D00.l/Dhk.0 D00.l/Å Dhk.0/Å D00.l/Dhk.0 D00.l/Å Dhk.0/Å D00.l/Dhk.0 D00.l/Å Dhk.0/Å D00.l/Dhk.0
1 254.63 46.63 5.5 128.52 25.25 5.1 202.29 34.55 5.9 124.25 31.94 3.9
2 231.14 44.07 5.2 168.9 30.5 5.5 220.8 40.7 5.4 188.2 45.2 4.2
4 241.13 46.48 5.2 161.7 32.6 5.0 213.1 44.2 4.8 193.8 50.1 3.9
48 229.46 81.79 2.8 218.8 45.3 4.8 221.6 67.1 3.3 257.1 78.6 3.3
96 305.26 94.73 3.2 260.2 52.7 4.9 251.6 70.5 3.6 289.6 84.3 3.4
Figure 5. Average crystallite size versus M content of the cAp and the
M-doped cAp nanocrystals synthesized at different times and at 80 °C
using the initial Ca/M molar ratio of 9:1.
Figure 6. (a) Unit cell volume and D00.l/Dhk.0 (= L/W) ratio (in the
inset) as a function of the reaction time and (b) unit cell volume
versus average crystal size of the undoped cAp and the M-doped cAp
nanocrystals synthesized at 80 °C using the initial Ca/M molar ratio of
9:1. The lines are simply included to show the tendencies.
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3.6. Cytotoxicity of M-Doped cAp Nanocrystals. The
toxicity of Mn2+- and Co2+-doped nanocrystals was tested in a
MTT assay on murine MS1 endothelial cells, after incubation at
different concentrations ranging from 100 to 0.1 μg/mL. No
significant toxicity was observed in the case of Mn2+-doped
nanoparticles at any nanoparticle concentration (Figure 8).
Indeed their values were superimposable to the ones of naiv̈e
undoped cAps, and in all cases cell viability was always higher
than 85%. In both cases, Mn-doped and undoped cAp
nanoparticles, the low toxicity observed displayed a dose-
dependent relationship. Nanoparticles doped with Co2+
displayed a certain level of cytotoxicity, especially at the 5:5
ratio (maximum 40% at the highest concentration), but toxicity
was still significantly low at the 9:1 ratio, cell survival being
around 80%. Also in this case, a dose-dependent relationship
was observed. Thus, since naiv̈e undoped nanoparticles
displayed already some cytotoxicity, the activity due to the
doping is insignificant for Mn-doped nanoparticles and limited
in the case of the Co (9:1) samples. On the other side these
cells were sensitive to the toxic activity of doxorubicin, which
reduced their viability to less than 40%.
4. DISCUSSION
In this work the precipitation of doped cAp nanocrystals with
some divalent transition metals has been carried out by thermal
decomplexing of Ca2+/M-citrate/phosphate/carbonate solu-
tions. According to our data, citrate plays different roles during
the doping process. First, the use of citrate as M-complexing
agent enables the preparation of metastable Ca2+/M/citrate/
phosphate/carbonate solutions at slightly basic pH that can be
easily destabilized by increasing the temperature, thus releasing
the M ions and leading to the precipitation of almost
monodisperse M-doped cAp nanoparticles. Second, owing to
the different stability of the M-citrate complexes (M = Mn2+,
Co2+, and Ni2+) and its dependence with temperature, citrate
controls the activity of hydrated cations in solution and
therefore the extension of the doping process. Third, citrate
protects the M ions against oxidation in solution as well as
those present in the outermost layer of doped nanocrystals.
During the doping process M substitutes Ca positions in the
cAp structure. We do not have enough data to properly assign
the substitution either in Ca(I) or Ca(II) positions, since these
Figure 7. TEM micrographs of doped-Ap crystallized after 96 h: (a)
Mn (9:1); (b) Co (9:1); and (c) Ni (9:1). Insets show the SAED
pattern and the point analysis collected for each sample.
Table 3. Mean length (L), width (W), and aspect ratio (R) of the cAp and the M-doped cAp nanoparticles synthesized at 80°C
using the initial Ca/M molar ratio of 9:1 and after a maturation time of 96 ha
sample M contentb / % Lc / Å Wc / Å Rc (= L/W) D00l / Å Dhk0 / Å D00l/Dhk0
Mn(9:1)-96h 2.78 243 ± 93 47 ± 13 5.17 ± 0.66 260 ± 7.4 52.7 ± 0.21 4.93 ± 0.03
Co(9:1)-96h 1.73 245 ± 154 73 ± 15 3.35 ± 0.83 252 ± 3.7 70.5 ± 0.20 3.57 ± 0.02
Ni(9:1)-96h 0.12 275 ± 170 85 ± 22 3.23 ± 0.94 289 ± 4.8 84.3 ± 0.27 3.42 ± 0.02
cAp-96h 292 ± 107d 123 ± 28d 2.5 ± 1.0d 305 ± 6.2 94.7 ± 0.38 3.22 ± 0.03
aAverage size (D) of crystal domains along the [00.l] and [hk.0] directions calculated from the microstructural analysis (XRD). bTransition metal
content (w/w). cMeasured from TEM micrographs. dValues from ref 13.
Figure 8. Cell viability of undoped cAp, Co-doped, and Mn-doped
cAp (prepared at 80 °C, crystallization time of 96 h).
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two positions are not equivalent. Site Ca(I) is smaller in volume
than site Ca(II). As the ionic radii of Mn2+ (0.080 nm), Co2+
(0.0745 nm), and Ni2+ (0.069 nm) are lower than ionic radius
of calcium of site (I) (0.099 nm), by simple reasoning one can
consider that Ca(I) positions are the preferred substitution site.
Nevertheless, M substitution in one or another position or in
both depends not only on the ionic radii but also on the
number (concentration) of doping M ions and the type and
amount of anions (as in this case CO3
2−) simultaneously
incorporated in the structure.19
Another interesting observation is the capability of all doping
metals to inhibit the growth of cAp nanocrystals. The inhibiting
effect of crystal growth is enhanced with the increase in M
content, irrespective of the nature of the M (Figure 5).
Amorphous calcium phosphates (ACP) are expected at higher
M contents. The trend of yielding ACP with the increase at
high levels of the M content has been also observed when
hydroxyapatite was doped with other metals, i.e., Mg2+.36
Unlike other works35 reporting the precipitation of Co-
hydroxyapatite particles in carboxylated free solutions in
which not only smaller sizes but lower aspect ratios were
found, in our experiments the average sizes decrease, whereas
the aspect ratio increases due of the strongest inhibition of the
growth in the (hk.0) caused by adsorption of citrate in these
planes. This finding proves the key role of citrate in shaping the
doped nanoparticles.
The growth mechanism of biomimetic nanocrystalline
apatites in the presence of citrate has been thoroughly
characterized in previous papers.13,16,17 Following this mecha-
nism, citrate drives the growth pathway via an amorphous
precursor stabilizing ACP at the early stage, controlling the
amorphous to apatite transformation and the nanocrystal size
by adsorption on the (10.0) face and equivalent planes. Then,
citrate influences the growth of nanocrystals by a nonclassical
oriented aggregation mechanism. The citrate molecule is too
large to be incorporated into the cAp crystal lattice. Therefore,
it remains bound to the crystal surface, preferably in the (10.0)
face and equivalent faces. This occurs because Ca2+ ions in the
(10.0) face, at the two different surface profiles or sublevels,
(10.0)1 and (10.0)2, are arranged with a spacing similar to the
distance between the centers of the carboxylate groups in
citrate.14 The incorporation of the studied divalent transition
metals, as well as Na+ and A-, B- carbonate ions substituents
most probably takes place during the formation of the
amorphous precursor and the progressive amorphous to apatite
transformation (from the core to the surface hydrated layer
containing the citrate and structural water molecules13). In
most cases M incorporation occurred in the first 4 h of the
experiment, and then the amount of M was kept constant, while
in the case of Co2+ (Figure 2) the M content increased with
time, likely during amorphous to cAp transformation, along the
whole maturation period. When the M content exceeds a
certain threshold (6.5 w/w% calculated in this work) the
amorphous calcium phosphate becomes stable. It is worth
noting the formation of Mn-doped cAp (Figure S1 of
Supporting Information), in which the content of Mn2+ after
the initial precipitation period decreases instead of increasing.
The release of M from the solid containing Na+ and A- and B-
carbonate ion substituents must be a mechanism to facilitate
charge compensation and spatial accommodation into the
crystalline structure.
The in vitro cell toxicity data confirm that the chemical/
electronic modification of these nanocrystals does not
significantly affect cell viability, with the exception of the
nanoparticles doped with a high ratio of Co2+. Indeed the low
toxicity levels are comparable with those observed in the case of
cell treatment with undoped nanoparticles. These data, taken
together, demonstrate the high biocompatibility degree of these
doped nanocrystals and sustain their use as possible
biodegradable supports for drug delivery, possibly enhanced
by active targeting mediated by probes recognizing specific cell
markers.
5. CONCLUSIONS
In this paper we have studied the incorporation of Mn2+, Co2+,
and Ni2+ in citrate−carbonate−apatite nanocrystals obtained by
precipitation from Ca/M//citrate/phosphate//carbonate sol-
utions as well as their influence on crystal growth, micro-
structure, colloidal stability, and cytotoxicity of precipitated
solids.
Besides its influence on the nucleation and crystal growth of
biomimetic nanocrystalline apatites, already reported, citrate
plays an active role also during the doping process. First, citrate
acts as M-complexing agent; second, it controls the activity of
hydrated M ions in solution and therefore the extension of the
doping process, and third, it protects the M ions against
oxidation in solution as well as in doped nanocrystals.
Different trends have been found during our study. First, the
growth of nanocrystals is clearly enhanced when temperature is
increased and M content is decreased. Second, for similar
crystallization conditions the amount of M incorporated
normally follows the order Mn2+ > Co2+> Ni2+. Third, the
higher the M content, the higher is the aspect ratio (L/W) of
M-doped compared to undoped cAp nanoparticles. Fourth,
when the M content is higher than 6.5 w/w%, the crystallinity
(long-range order) of the nanoapatites is lost. Fifth, the
colloidal stability of nanoaparticles suspensions decreased in the
order: undoped, Mn-, Ni-, and Co-doped cAp. Moreover, the
cytotoxicity evaluation revealed that the produced Mn- and Co-
doped cAp are highly biocompatible at doses comparable to
those of undoped cAp, with the exception of those nano-
particles doped with the higher Co2+ content at the higher
doses.
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(13) Delgado-Loṕez, J. M.; Iafisco, M.; Rodríguez, I.; Prat, M.;
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